[go: up one dir, main page]

EE200200353A - Inimese heparanaasisarnane polüpeptiid ja nukleiinhape - Google Patents

Inimese heparanaasisarnane polüpeptiid ja nukleiinhape

Info

Publication number
EE200200353A
EE200200353A EEP200200353A EEP200200353A EE200200353A EE 200200353 A EE200200353 A EE 200200353A EE P200200353 A EEP200200353 A EE P200200353A EE P200200353 A EEP200200353 A EE P200200353A EE 200200353 A EE200200353 A EE 200200353A
Authority
EE
Estonia
Prior art keywords
polypeptide
nucleic acid
human heparanase
heparanase
human
Prior art date
Application number
EEP200200353A
Other languages
English (en)
Estonian (et)
Inventor
Siemeister Gerhard
Weiss Bertram
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200353A publication Critical patent/EE200200353A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01139—Alpha-glucuronidase (3.2.1.139)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200200353A 1999-12-23 2000-12-18 Inimese heparanaasisarnane polüpeptiid ja nukleiinhape EE200200353A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125831 1999-12-23
PCT/EP2000/012909 WO2001048161A2 (fr) 1999-12-23 2000-12-18 Acide nucleique et polypeptide apparentes a l'heparanase humaine

Publications (1)

Publication Number Publication Date
EE200200353A true EE200200353A (et) 2003-10-15

Family

ID=8239724

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200353A EE200200353A (et) 1999-12-23 2000-12-18 Inimese heparanaasisarnane polüpeptiid ja nukleiinhape

Country Status (20)

Country Link
US (1) US20040161745A1 (fr)
EP (1) EP1244778A2 (fr)
JP (1) JP2003518381A (fr)
KR (1) KR20020062375A (fr)
CN (1) CN1413249A (fr)
AU (1) AU3013901A (fr)
BG (1) BG106842A (fr)
BR (1) BR0016703A (fr)
CA (1) CA2392703A1 (fr)
CZ (1) CZ20022147A3 (fr)
EE (1) EE200200353A (fr)
HU (1) HUP0203724A2 (fr)
IL (1) IL149506A0 (fr)
MX (1) MXPA02005077A (fr)
NO (1) NO20023015L (fr)
PL (1) PL362867A1 (fr)
RU (1) RU2002119561A (fr)
SK (1) SK8882002A3 (fr)
WO (1) WO2001048161A2 (fr)
ZA (1) ZA200205852B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072973A2 (fr) * 2000-02-24 2001-10-04 Bayer Aktiengesellschaft Regulation d'une enzyme humaine de type heparanase
GB0008912D0 (en) * 2000-04-11 2000-05-31 Janssen Pharmaceutica Nv Mammalian heparanase
US20020064853A1 (en) * 2000-04-20 2002-05-30 Heinrikson Robert Leroy Heparanase II, a novel human heparanase paralog
WO2002004645A2 (fr) * 2000-07-12 2002-01-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Deuxieme heparanase humaine et ses variantes epissees a expression predominante dans les muscles du squelette, du coeur et du pancreas
FR2818131B1 (fr) * 2000-12-14 2005-02-11 Oreal Composition cosmetique comprenant de l'heparanase
CN101311188B (zh) * 2007-05-21 2010-12-29 中国人民解放军军事医学科学院生物工程研究所 人乙酰肝素酶的小分子多肽抑制剂
CN101670115B (zh) * 2009-07-31 2011-07-27 中国人民解放军第三军医大学 乙酰肝素酶与热休克蛋白的复合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
CN1280613A (zh) * 1997-10-28 2001-01-17 澳大利亚国立大学 编码哺乳动物内切葡糖醛酸糖苷酶的分离的核酸分子及其应用
MXPA01011708A (es) * 1999-06-25 2003-09-10 Insight Strategy & Marketing Polinucleotidos que codifican polipeptidos distantemente homologos a heparanasa.
EP1214423A1 (fr) * 1999-09-23 2002-06-19 MERCK PATENT GmbH L'heparanase-2, membre de la famille des proteines heparanases

Also Published As

Publication number Publication date
BG106842A (en) 2003-05-30
US20040161745A1 (en) 2004-08-19
AU3013901A (en) 2001-07-09
EP1244778A2 (fr) 2002-10-02
CZ20022147A3 (cs) 2002-09-11
HUP0203724A2 (hu) 2003-03-28
CN1413249A (zh) 2003-04-23
ZA200205852B (en) 2003-10-22
NO20023015D0 (no) 2002-06-21
PL362867A1 (en) 2004-11-02
BR0016703A (pt) 2002-09-24
JP2003518381A (ja) 2003-06-10
CA2392703A1 (fr) 2001-07-05
MXPA02005077A (es) 2002-11-07
WO2001048161A2 (fr) 2001-07-05
KR20020062375A (ko) 2002-07-25
SK8882002A3 (en) 2002-11-06
WO2001048161A3 (fr) 2002-02-14
RU2002119561A (ru) 2004-02-10
NO20023015L (no) 2002-06-21
IL149506A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
NO983364L (no) Konsensusproteiner
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE9900357A (et) Geenisekvenaator ja meetodid
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
EE200200282A (et) Keemilised meetodid ja vaheühendid
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
EP1186615A4 (fr) Proteine et adn de cette proteine
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
NO20021305D0 (no) DNA-konstruksjon og dens anvendelse
DE69837507D1 (de) Humanes Hedgehog-Protein
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
FI990973A7 (fi) Harvesteripää ja menetelmä siinä
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI971872L (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
NO20016089D0 (no) Nuklein- og proteinsyrer som svarer til det humane gen ABC1
GB0021008D0 (en) Protein and nucleic acid sequence
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
EP1229795A4 (fr) Chimiokine beta 13 humaine
EP1077258A4 (fr) Gene hrpi humain
DK1216021T3 (da) Farmaceutiske og/eller kosmetiske præparater
EP1234032A4 (fr) Nouvel acide nucleique et nouveau polypeptide
EE200200168A (et) PRV-1-geen ja selle kasutamine
EP1254256A4 (fr) Nouveaux acides nucleiques et polypeptides associes
DE60020862D1 (de) 7-acylamino-3-heteroarylthio-3-cephemcarbonsäure antibiotika und deren vorwirkstoffe
NO20006091D0 (no) Humant protein C-polypeptid